T Sasazuki|S Shirasawa - JoVE Visualize

Showing results (1-10 of 210) with videos related to

Pageof 21

Sort By:

Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1991

[Diagnosis of colorectal cancer from DNA level]S Shirasawa, Y Yanagawa, T Sasazuki

Science (New York, N.Y.)|April 2, 1993

Altered growth of human colon cancer cell lines disrupted at activated Ki-rasS Shirasawa, M Furuse, N Yokoyama, et al.

Cancer Research|May 27, 1999

Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cellsK Okumura, S Shirasawa, M Nishioka, et al.

Cancer Research|November 14, 1997

Activated Ki-ras enhances sensitivity of ceramide-induced apoptosis without c-Jun NH2-terminal kinase/stress-activated protein kinase or extracellular signal-regulated kinase activation in human colon cancer cellsM Ohmori, S Shirasawa, M Furuse, et al.

British Journal of Cancer|September 2, 1999

Targeted disruption of the K-ras oncogene in an invasive colon cancer cell line down-regulates urokinase receptor expression and plasminogen-dependent proteolysisH Allgayer, H Wang, S Shirasawa, et al.

The Japanese Journal of Human Genetics|December 31, 2002

Suppression of serum-induced c-jun expression by activated Ki-ras in human colon cancer cellsM Furuse, S Shirasawa, K Okumura, et al.

Oncogene|January 29, 2008

Low-dose metronomic cyclophosphamide treatment mediates ischemia-dependent K-ras mutation in colorectal carcinoma xenograftsS Shahrzad, S Shirasawa, T Sasazuki, et al.

Cancer Research|June 1, 1991

p53 gene mutations in colorectal tumors from patients with familial polyposis coliS Shirasawa, K Urabe, Y Yanagawa, et al.

Oncogene|October 4, 2006

STAT1-independent inhibition of cyclooxygenase-2 expression by IFNgamma; a common pathway of IFNgamma-mediated gene repression but not gene activationL Klampfer, J Huang, P Kaler, et al.

Cancer Research|October 15, 1995

Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesisJ Rak, Y Mitsuhashi, L Bayko, et al.

Pageof 21

Showing results (1-10 of 210) with videos related to

Sort By:

Pageof 21

Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1991

[Diagnosis of colorectal cancer from DNA level]S Shirasawa, Y Yanagawa, T Sasazuki

Science (New York, N.Y.)|April 2, 1993

Altered growth of human colon cancer cell lines disrupted at activated Ki-rasS Shirasawa, M Furuse, N Yokoyama, et al.

Cancer Research|May 27, 1999

Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cellsK Okumura, S Shirasawa, M Nishioka, et al.

Cancer Research|November 14, 1997

Activated Ki-ras enhances sensitivity of ceramide-induced apoptosis without c-Jun NH2-terminal kinase/stress-activated protein kinase or extracellular signal-regulated kinase activation in human colon cancer cellsM Ohmori, S Shirasawa, M Furuse, et al.

British Journal of Cancer|September 2, 1999

Targeted disruption of the K-ras oncogene in an invasive colon cancer cell line down-regulates urokinase receptor expression and plasminogen-dependent proteolysisH Allgayer, H Wang, S Shirasawa, et al.

The Japanese Journal of Human Genetics|December 31, 2002

Suppression of serum-induced c-jun expression by activated Ki-ras in human colon cancer cellsM Furuse, S Shirasawa, K Okumura, et al.

Oncogene|January 29, 2008

Low-dose metronomic cyclophosphamide treatment mediates ischemia-dependent K-ras mutation in colorectal carcinoma xenograftsS Shahrzad, S Shirasawa, T Sasazuki, et al.

Cancer Research|June 1, 1991

p53 gene mutations in colorectal tumors from patients with familial polyposis coliS Shirasawa, K Urabe, Y Yanagawa, et al.

Oncogene|October 4, 2006

STAT1-independent inhibition of cyclooxygenase-2 expression by IFNgamma; a common pathway of IFNgamma-mediated gene repression but not gene activationL Klampfer, J Huang, P Kaler, et al.

Cancer Research|October 15, 1995

Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesisJ Rak, Y Mitsuhashi, L Bayko, et al.

Pageof 21